chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Just a bit of discoloration; Little blister; injection arm it swelled up significantly; Arm red from below her injection site to her elbow; hot with a temperature; allergic reaction to the vaccine; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of ADMINISTRATION SITE DISCOLOURATION (Just a bit of discoloration), BLISTER (Little blister), VACCINATION SITE SWELLING (injection arm it swelled up significantly), VACCINATION SITE ERYTHEMA (Arm red from below her injection site to her elbow) and PYREXIA (hot with a temperature) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025J20-2a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Previously administered products included for Product used for unknown indication: Sulfa and penicillin. Past adverse reactions to the above products included Rash with Sulfa and penicillin. Concomitant products included LEVOTHYROXINE for an unknown indication.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ADMINISTRATION SITE DISCOLOURATION (Just a bit of discoloration), BLISTER (Little blister), VACCINATION SITE SWELLING (injection arm it swelled up significantly), VACCINATION SITE ERYTHEMA (Arm red from below her injection site to her elbow) and PYREXIA (hot with a temperature). an unknown date, the patient experienced HYPERSENSITIVITY (allergic reaction to the vaccine). The patient was treated with IBUPROFEN for Fever, at an unspecified dose and frequency; PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency and AMMONIUM CHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE, MENTHOL, SODIUM CITRATE (BENADRYL [AMMONIUM CHLORIDE;DIPHENHYDRAMINE HYDROCHLORIDE;MENTHOL;SODIUM CITRATE]) for Adverse event, at an unspecified dose and frequency. At the time of the report, ADMINISTRATION SITE DISCOLOURATION (Just a bit of discoloration), BLISTER (Little blister), VACCINATION SITE ERYTHEMA (Arm red from below her injection site to her elbow), PYREXIA (hot with a temperature) and HYPERSENSITIVITY (allergic reaction to the vaccine) outcome was unknown and VACCINATION SITE SWELLING (injection arm it swelled up significantly) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 100.5 (High) Fever.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Upper left arm began hurting around 5-6 days after the second shot; pain at times was severe, other times was like a dull ache. Pain extended occasionally down the arm into the hand, and up the left side of my neck, as well as around the back to the left shoulder blade. Pain sometimes better in the morning but increased throughout the day, even though I took great care not to use my left arm for anything strenuous. Range of motion was limited; I couldn't raise the arm more than shoulder height without pain. Pain has continued for nearly a month, and has gotten only slightly less painful. To the best of my knowledge this is due to the vaccination and not something I did that strained or injured my arm.
Uncontrollable crying for about 3 hours.  Vomiting of milk and phlegm, choking and hard time breathing, pounding on his head with his hands.
Patient received the 2nd dose of Moderna vaccine. She  was observed for 15 minutes- towards the end of the 15 minutes she reported dizziness and nausea. BP 130/86 HR: 90 O2SAT 98%.  She was observed for another 15 minutes, she reported no improvement. 911 called. Vitals 140/86,  HR 91, 98%,  Blood sugar 176- per paramedics. Patient will be transported to hospital
severe headache; cough; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; solution for injection, lot number, expiration date was not reported), via an unspecified route of administration, on 23Mar2021, at dose number unknown, single for covid-19 immunization. The patient medical history and concomitant medications were not reported. The patient experienced severe headache, cough on Mar2021. The outcome of the events was unknown.    No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Vaccine was done at 2:50. Around 6pm I started getting a headache, neck pain and my lymph nodes were enlarged. Took 1000mg of Tylenol. At 1030 pm, I started getting all over muscle spasms, headache returned, onset of dizziness, nausea and uncontrollable shaking. At 1145pm, I started vomiting, the muscle spasms got increasing  worse, the shaking only decreased while in the bath tub in very hot water. No fever was noted with thermometer, but after a second dose of 1000mg of Tylenol at 1am, I broke out profusely sweating 30 minutes later.  The uncontrollable shaking stoped at about 4am, along with the nausea and vomiting.  Upon waking up the next day, muscle spasms were still there as well as the headache and dizziness. By end of day 4-10-21 (today) all symptoms have resolved but the headache.
Patient presented at the pharmacy on Friday, Oct 5, with what appeared to be bruising about 4 inches below the injection sight. She said the bruising had started up a little higher and had moved down. She reported no pain, no swelling, no fever, no itching. She just happened to notice the redness on her arm.
I experienced sore throat and cold and sinus infection that last 3-4 days then following that I started to experience fatigue and being tired as if I was out of shape, I would feel winded and very fatigued.
No adverse event; 2.5ml dose administered instead of a 0.5ml dose; This spontaneous case was reported by a nurse and describes the occurrence of ACCIDENTAL OVERDOSE (2.5ml dose administered instead of a 0.5ml dose) and NO ADVERSE EVENT (No adverse event) in a  patient of an unknown age and gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Sep-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 2.5 milliliter. On 15-Sep-2022, the patient experienced ACCIDENTAL OVERDOSE (2.5ml dose administered instead of a 0.5ml dose). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, ACCIDENTAL OVERDOSE (2.5ml dose administered instead of a 0.5ml dose) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for ACCIDENTAL OVERDOSE (2.5ml dose administered instead of a 0.5ml dose).    No concomitant medication details was reported. No treatment medication details was reported.
Patient received her first Pfizer covid vaccine in the morning of Thursday, 2/3/22, and by the late evening on 2/3/22, she was weak, fatigued, fever and had significant myalgias and arthralgias. Slept through Friday morning at 1000. By Friday afternoon, she was very aggressive, and agitated. She was having trouble flexing and extending her fingers and was unable to speak. Had significant headache and was unable to swallow. Went to the ER on 2/6/22 where she was noted to be confused, nervous, anxious. She had difficulty moving her tongue to the right, delayed stuttering speech. Stroke alert called and was admitted to the Hospital.
Chest pain and tachycardia (100-130 bpm at resting) with periodic palpitations beginning at 6am the day after injection (14Apr2021) and lasting for 2 days.  One dose (25mg) of my PRN medication metoprolol on 14Apr2021 produced no improvement in symptoms.  Short-term improvement (but not full resolution) in chest pain and tachycardia for several hours noted on 15Apr2021 after taking 3 chewable low dose aspirin but full resolution was not until 16Apr2021 .   Blood pressure simultaneously elevated at 150/92 at resting on 14Apr2021 and fully resolved to normal 120/75 on 15Apr2021.
3" circular pink/red rash at injection site, rash was warm ~99 degrees f, itchy, tender
Administered vaccine that was stored at temperature between -80 degree F to -84 degree F; Administered vaccine that was stored at temperature between -80 degree F to -84 degree F; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT STORAGE ERROR (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F) and POOR QUALITY PRODUCT ADMINISTERED (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F) in a 40-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 076C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Nov-2021 at 1:33 PM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 16-Nov-2021 at 1:33 PM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F). At the time of the report, PRODUCT STORAGE ERROR (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F) and POOR QUALITY PRODUCT ADMINISTERED (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. It was reported that the patient was administered the vaccine that underwent temperature excursion.Information on patient diagnosed with or tested positive for COVID-19 was unknown. It was reported that the vaccine was stored in an ultra cold freezer at minus 82 degrees Fahrenheit. It was reported that the storage condition at the  time of temperature excursion was frozen storage. Maximum temperature reached was reported as negative 82 degrees Fahrenheit. The excursion duration was 1 month. It was reported that the Moderna COVID-19 vaccine vials were moved from super cold freezer to the refrigerator on 19 Nov 2021. It was reported that 70 vials were still in ultra cold freezer and 8 vials were in the refrigerator. It was reported that no vaccine state changes were noticed and the vaccines were never refrozen. The proposed desired use by date was 07 Dec 2021.  No treatment medications were reported.   This case was linked to MOD-2021-402935 (Patient Link).
Patient received higher than the recommend dose of vaccine.  0.20 micgrograms in 0.2 mL syringe given of both Pfizer vaccine lot Fl8094 Exp and vaccine lot Fk9894 Exp.
Fullness in inner ears, ear discomfort, lightheadedness, dizziness, vertigo-esque symptoms for about a week to 10 days. Significantly/moderately severe for 4 days, then gradually lessening.
Initial report received from a healthcare professional on 23 October 2014. A 58-year old female patient, whose medical history and concomitant medications were not reported, had received a dose of Flu vaccine via intramuscular route (dose, batch number, dose number and site of administration were not reported) on 14 Oct 2014. On an unspecified date, the patient experienced pain in her arm and described it as throbbing, stabbing with pins and needles. The patient consulted doctor on 15 Dec 2014 and the physician assessed the pain was probably from the flu shot. Laboratory investigations and corrective treatments were not reported. At the time of this report, the event outcome was unknown. Documents held by sender: none.
Iliac vein thrombosis pt started with right lower quadrant abdominal pain six days after vaccine.  Persistent pain since then leading to hospital stay and diagnosis on imaging of right iliac vein thrombosis. no prior history of DVT, no family history of DVT, no inciting event/travel/change in activity level/surgery/illness
Pt vaccinated /w 1st dose of Recombivax, developed dizziness, blurred vision, jitteriness, sweating, myalia, vomiting, nause, vertigo, disorientation & pain in eye. Exam revealed Pt's fundi & intraocular pressure WNL. Pt hospitalized.
Swelling to upper lip and around nose. Tongue tingling. Patient given 25mg of liquid Benadryl. Within approximately 20 minutes the patient's swelling began to subside. Patient felt better and tongue was no longer tingling.
Very weak overall but especially muscles after vaccination. Fractured my sesmoid bone within the week of vaccination without any recollection of how it could have happened and never having any bone fractures previously.
VACCINE ADMINISTERED WHICH WAS STORED OUTSIDE OF THE RECOMMENDED STORAGE CONDITIONS; VACCINE STORED AT ROOM TEMPERATURE (BELOW 77 F) FOR ABOUT 24 -25 HOURS (STORED AT 36 C INSTEAD OF 36 F); This spontaneous report received from a physician concerned multiple patients.  No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1855191 expiry: 11-APR-2022) dose was not reported, administered on 17-NOV-2021 for prophylactic vaccination. No concomitant medications were reported. On 17-NOV-2021, the patient experienced vaccine administered which was stored outside of the recommended storage conditions. On 17-NOV-2021, the patient experienced vaccine stored at room temperature (below 77 f) for about 24 -25 hours (stored at 36 c instead of 36 f). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the vaccine stored at room temperature (below 77 f) for about 24 -25 hours (stored at 36 c instead of 36 f) and vaccine administered which was stored outside of the recommended storage conditions was not reported. This report was non-serious.
sore arms; Initial information received on 25-Oct-2021 regarding an unsolicited valid social media  non-serious case from a consumer/non-healthcare professional.  This case involves a patient (unknown age and gender) who had sore arms (pain in extremity) after receiving INFLUENZA VACCINE and Coronavirus disease of 2019 (COVID-19 VACCINE).  It was unknown if the patient had any medical history, concomitant disease or risk factor.  The patient's past medical treatment(s), vaccination(s) and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer and COVID-19 VACCINE not produced by Sanofi Pasteur (lot numbers and expiry dates not reported) via unknown route in an unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed a non-serious sore arms (pain in extremity) (unknown latency) following the administration of vaccines.  It was unknown if the patient experienced any additional symptoms/events.  It was unknown if there were laboratory data/results available.  It was not reported if the patient received a corrective treatment.  At time of reporting, the outcome for the event was unknown.  There will be no information on the batch available for this case.
Subsequent to receiving first dose of Lymerix the pt was found to be pregnant. The date of conception is 07/20/2000 and the estimated date of delivery is 04/03/2001. Lymerix was discontinued. A doctor visit was required. As of 09/07/2000 the outcome of the event is unknown.
He had the vaccine and 3/1/21 he had numbness on the right side of his mouth.  His eye started watering as well .  Mother took him to the doctor who diagnosed him with Bell's Palsy.   Dr. prescribed Prednisone and Valacyclovir for these symptoms.  He still has some drooping of his eye and mouth, but doctor said it may take a couple of weeks.  He does have blurry vision due to this as well.  The injection site itself has no problems.   He has a FU next week with his doctor.
Couldn't grip anything with her hands; Started presenting an excruciating back pain after making a specific movement; 102°F fever; Nausea; Extreme shaking; Migraine; When the fever was high she developed a pretty consistent dry cough; This spontaneous case was reported by a consumer and describes the occurrence of TREMOR (Extreme shaking), MIGRAINE (Migraine), COUGH (When the fever was high she developed a pretty consistent dry cough), BACK PAIN (Started presenting an excruciating back pain after making a specific movement) and PYREXIA (102°F fever) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011M20A and 003A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 05-Mar-2021, the patient experienced TREMOR (Extreme shaking), MIGRAINE (Migraine), COUGH (When the fever was high she developed a pretty consistent dry cough), PYREXIA (102°F fever) and NAUSEA (Nausea). On 06-Mar-2021, the patient experienced BACK PAIN (Started presenting an excruciating back pain after making a specific movement). On an unknown date, the patient experienced MUSCULAR WEAKNESS (Couldn't grip anything with her hands). The patient was treated with Physical therapy for Back pain. At the time of the report, TREMOR (Extreme shaking), MIGRAINE (Migraine), COUGH (When the fever was high she developed a pretty consistent dry cough), NAUSEA (Nausea) and MUSCULAR WEAKNESS (Couldn't grip anything with her hands) outcome was unknown and BACK PAIN (Started presenting an excruciating back pain after making a specific movement) and PYREXIA (102°F fever) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 05-Mar-2021, Body temperature: 102 (High) 102.         This case was linked to MOD-2021-068265 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 20-May-2021: Non significant follow up received on 20-MAY-2021, event updated; Sender's Comments:  MOD-2021-068265:Same reporter
did not receive their second dose, it has been over 2 years; This case was reported by a other health professional via interactive digital media and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose 2 years ago from the date of reporting).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The age at vaccination was not applicable for this report. The reporter asked, if the patient did not receive their second dose of Shingrix withing 2-6 months and it has been over 2 years, did they need to repeat the series. Till the time of reporting, the patient, did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination.
Pt received vaccine in afternoon of 01/13/2006, developed generalized hives the morning of 01/14/2006. Seen in ER, received Benadryl PO. Took PO Benadryl x 2 days.
Itchy rash at injection site.  Used hydrocortisone cream and it is relieving.   Pt didn't  need medical attention and didn't think he needed to call his doctor.  Unsure of when rash officially started so just put the day after but pt should be able to answer that if contacted.
SEVERE pain/ in shoulder , limp elbow; tiredness in shoulder , limp elbow; limp elbow and hand; I've waked at 3 am; This case was reported by a consumer and described the occurrence of shoulder pain in a 74-year-old patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On 9th June 2021 21:00, the patient received Shingles vaccine. In June 2021, 6 hrs after receiving Shingles vaccine, the patient experienced shoulder pain, muscle fatigue, mobility decreased and sleep disturbance. The patient was treated with paracetamol (Tylenol). On an unknown date, the outcome of the shoulder pain, muscle fatigue, mobility decreased and sleep disturbance were not recovered/not resolved.   It was unknown if the reporter considered the shoulder pain, muscle fatigue, mobility decreased and sleep disturbance to be related to Shingles vaccine.  Additional information was provided as follows: On 9th June 2021, the patient had Shingles vaccination in evening about 9 pm. On 10th June 2021 about 3 am, the patient woke up in severe pain and tiredness in shoulder, limp elbow and hand. The patient applied ice and took two Tylenol. The patient asked what else should be done.
I received Pfizer dose #1 on 1/13/21 with no AE.  I received Pfizer dose #2 on Mon 2/1/21.  On  Wed 2/3/21, I awoke with hives on my neck and chest, I took a Clarinex.  The hives progressed t/o the day.  I took a Benadryl that evening.  I had difficulty sleeping d/t the burning and itching.  I took another Benadryl at 0130 on 2/4/21.  By 0930 on 2/4/21 my entire torso and scalp was inflamed.  My shoulders were swollen.   I had difficulty swallowing.  I had a sudden "brain fog" with difficulty speaking and a major headache.  I took another Benadryl.  I then slept for 21 hours with a half hour awake period for lunch and scheduled Benadryl every 6  hours.  My PCP recommended Pepcid 20 mg po BID x 5 days so I started that as well, and I took tylenol for the headache.  The next day my rash had improved.  I was tired but not extremely fatigued like the day prior.  I gradually felt better t/o the day.  Saturday 2/6/21, I awoke with resolution of all s/s.
On day 5 - back pain - noticeable hives primarily to (L) lateral trunk. Swelling & erythema with localized papules to (L) thigh.
Delayed itching/swelling of left arm (1 week after vaccination); diarrhea and abdominal pain (ongoing x 10 days since vaccine)